<VariationArchive VariationID="345943" VariationName="NM_000387.6(SLC25A20):c.326+1del" VariationType="Deletion" Accession="VCV000345943" Version="20" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-17" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="295347" VariationID="345943">
      <GeneList>
        <Gene Symbol="SLC25A20" FullName="solute carrier family 25 member 20" GeneID="788" HGNC_ID="HGNC:1421" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48856926" stop="48898882" display_start="48856926" display_stop="48898882" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48894355" stop="48936425" display_start="48894355" display_stop="48936425" Strand="-" />
          </Location>
          <OMIM>613698</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000387.6(SLC25A20):c.326+1del</Name>
      <CanonicalSPDI>NC_000003.12:48883995:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48883996" stop="48883996" display_start="48883996" display_stop="48883996" variantLength="1" positionVCF="48883995" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48921429" stop="48921429" display_start="48921429" display_stop="48921429" variantLength="1" positionVCF="48921428" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000387.5" sequenceAccession="NM_000387" sequenceVersion="5" change="c.326+1delG">
            <Expression>NM_000387.5:c.326+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48921430del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48921430del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48883997del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48883997del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008171.1" sequenceAccession="NG_008171" sequenceVersion="1" change="g.19901del">
            <Expression>NG_008171.1:g.19901del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000387.6" sequenceAccession="NM_000387" sequenceVersion="6" change="c.326+1del" MANESelect="true">
            <Expression>NM_000387.6:c.326+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2387439" DB="ClinGen" />
        <XRef Type="rs" ID="757552268" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000387.6(SLC25A20):c.326+1del AND Carnitine acylcarnitine translocase deficiency" Accession="RCV000389536" Version="16">
        <ClassifiedConditionList TraitSetID="3286">
          <ClassifiedCondition DB="MedGen" ID="C0342791">Carnitine acylcarnitine translocase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-24" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000387.6(SLC25A20):c.326+1del AND not provided" Accession="RCV000478253" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000387.6(SLC25A20):c.326+1del AND SLC25A20-related disorder" Accession="RCV003972463" Version="1">
        <ClassifiedConditionList TraitSetID="94065">
          <ClassifiedCondition>SLC25A20-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-24" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11350184</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11592821</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15365988</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16919490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25614308</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-04-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="94065" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="75323" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SLC25A20-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">SLC25A20-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="3286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10955" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carnitine acylcarnitine translocase deficiency</ElementValue>
                <XRef ID="Carnitine-Acylcarnitine+Translocase+Deficiency/1115" DB="Genetic Alliance" />
                <XRef ID="238003000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CACTD</ElementValue>
                <XRef Type="MIM" ID="212138" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1123" />
                <XRef ID="1123" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine-acylcarnitine translocase (CACT) is a critical component of the carnitine shuttle, which facilitates the transfer of long-chain fatty acylcarnitines across the inner mitochondrial membrane. CACT deficiency causes a defect in mitochondrial long-chain fatty acid ß-oxidation, with variable clinical severity. Severe neonatal-onset disease is most common, with symptoms evident within two days after birth; attenuated cases may present in the first months of life. Hyperammonemia and cardiac arrhythmia are prominent in early-onset disease, with high rates of cardiac arrest. Other clinical features are typical for disorders of long-chain fatty acid oxidation: poor feeding, lethargy, hypoketotic hypoglycemia, hypotonia, transaminitis, liver dysfunction with hepatomegaly, and rhabdomyolysis. Univentricular or biventricular hypertrophic cardiomyopathy, ranging from mild to severe, may respond to appropriate dietary and medical therapies. Hyperammonemia is difficult to treat and is an important determinant of long-term neurocognitive outcome. Affected individuals with early-onset disease typically experience brain injury at presentation, and have recurrent hyperammonemia leading to developmental delay / intellectual disability. Affected individuals with later-onset disease have milder symptoms and are less likely to experience recurrent hyperammonemia, allowing a better developmental outcome. Prompt treatment of the presenting episode to prevent hypoglycemic, hypoxic, or hyperammonemic brain injury may allow normal growth and development.</Attribute>
                <XRef ID="NBK582032" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35862567</ID>
                <ID Source="BookShelf">NBK582032</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="159" DB="Orphanet" />
              <XRef ID="C0342791" DB="MedGen" />
              <XRef ID="MONDO:0008918" DB="MONDO" />
              <XRef Type="MIM" ID="212138" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="758733" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="619145" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000445212" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11592821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16919490</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11350184</ID>
          </Citation>
          <Comment>The SLC25A20 c.326+1delG variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. The variant has been reported in three studies in which it is found in a total of four individuals with carnitine-acylcarnitine translocase deficiency including in a homozygous state in two siblings and in a compound heterozygous state in two unrelated individuals (Yang et al. 2001; Hsu et al. 2001; Korman et al. 2006). The c.326+1delG variant was absent from 30 healthy controls and is reported at a frequency of 0.00006 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies in individual fibroblasts showed a total absence of CACT enzyme activity while RT-PCR analysis revealed the variant resulted in skipping of either exon 3 or both exon 3 and exon 4 in individual RNA (Yang et al. 2001; Hsu et al. 2001; Korman et al. 2006). Based on the collective evidence and potential impact of splice site variants, the c.326+1delG variant is classified as pathogenic for carnitine-acylcarnitine translocase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A20" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="A" referenceAllele="AC" start="48921428" stop="48921429" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000387.5:c.326+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="212138" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794836" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000387.5:c.326+1delG|MedGen:C0342791" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000918216" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11350184</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11592821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16919490</ID>
          </Citation>
          <Comment>Variant summary: SLC25A20 c.326+1delG is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Five out five computational tools predict a significant impact on normal splicing consistent with multiple publications reporting experimental evidence that this variant affects mRNA splicing (Yang_2001, Hsu_2001). The variant allele was found at a frequency of 2.5e-05 in 244468 control chromosomes (gnomAD). c.326+1delG has been reported in the literature in multiple individuals affected with Carnitine-Acylcarnitine Translocase Deficiency (Yang_2001, Hsu_2001, Korman_2006), at-least one of whom was reported to have no Carnitine Acyltranslocase activity (Korman_2006). These data indicate that the variant is very likely to be associated with disease. Two ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant as likely pathogenic/pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A20" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000387.5:c.326+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Carnitine acylcarnitine translocase deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0342791" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1101484" SubmissionDate="2023-01-25" DateLastUpdated="2023-02-07" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:257636" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000566377" DateUpdated="2023-02-07" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Observed in trans with another variant in SLC25A20 in unrelated patients with SLC25A20-related carnitine-acylcarnitine translocase deficiency (Hsu et al., 2001; Korman et al., 2006); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32070364, 25614308, 33634872, 31589614, 36109795, 11592821, 11350184, 16919490)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A20" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="3" alternateAllele="-" referenceAllele="C" start="48921429" stop="48921429" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:396745</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_161_20230125054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1840072" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="941197|MedGen:C0342791" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000946050" DateUpdated="2024-02-20" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25614308</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11350184</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11592821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15365988</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16919490</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (Splice site) in the SLC25A20 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC25A20 are known to be pathogenic (PMID: 25614308). This variant is present in population databases (rs757552268, gnomAD 0.005%). This premature translational stop signal has been observed in individuals with carnitine-acylcarnitine translocase deficiency (PMID: 11350184, 11592821, 15365988, 16919490). This variant is also known as 388 1-G deletion and 326+1del. ClinVar contains an entry for this variant (Variation ID: 345943). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A20" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48921429del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342791" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8870903" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="5928196|SLC25A20-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004789609" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SLC25A20 c.326+1delG variant is predicted to result in a deletion affecting a canonical splice site. This variant has been reported in the homozygous or compound heterozygous state in clinically affected individuals with enzymatically or biochemically confirmed carnitine-acylcarnitine translocase (CACT) deficiency (Yang et al 2001. PubMed ID: 11350184, described as 388g deletion; Korman SH et al 2006. PubMed ID: 16919490; Bhattacharya K et al 2020. PubMed ID: 32070364). RNA studies have shown that the c.326+1del variant leads to aberrant splicing, primarily skipping of SLC25A20 exon 3 or exons 3 and 4 together (Yang et al 2001. PubMed ID: 11350184; Korman SH et al 2006. PubMed ID: 16919490). This variant is reported in 0.0080% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-48921428-AC-A). Taken together, this variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A20" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000387.5:c.326+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SLC25A20-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7859103" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000387.6:c.326+1del|OMIM:212138" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201713" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000387.6:c.326+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="212138" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7859103" TraitType="Disease" MappingType="XRef" MappingValue="212138" MappingRef="OMIM">
        <MedGen CUI="C0342791" Name="Carnitine acylcarnitine translocase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="758733" TraitType="Disease" MappingType="XRef" MappingValue="212138" MappingRef="OMIM">
        <MedGen CUI="C0342791" Name="Carnitine acylcarnitine translocase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1840072" TraitType="Disease" MappingType="XRef" MappingValue="C0342791" MappingRef="MedGen">
        <MedGen CUI="C0342791" Name="Carnitine acylcarnitine translocase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101484" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8870903" TraitType="Disease" MappingType="Name" MappingValue="SLC25A20-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="SLC25A20-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1794836" TraitType="Disease" MappingType="Name" MappingValue="Carnitine acylcarnitine translocase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0342791" Name="Carnitine acylcarnitine translocase deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528398</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002020662</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

